We will constantly evaluate partnership opportunities that will help to transform the future of treatment for immune-mediated diseases and cancer. BioRay is a commercial-stage biopharmaceutical company with a full suite of end-to-end capabilities in China. We seek to be the partner of choice with our industry-leading commercial scale manufacturing capacity, full spectrum R&D capabilities from drug discovery to formulation, and well-established nationwide commercial operations.